TEM
Tempus Ai, Inc.
A maker of AI-driven precision medicine tools, Tempus runs a platform that analyzes tumor samples and other health data to help doctors personalize cancer, hereditary, and neuropsychiatry care. Its Diagnostics line performs genomic tests, while Data & Applications sells anonymized health insights and trial-matching services to drugmakers. Founded in 2015 by Eric Lefkofsky, it takes its name from the Latin for "time" — a nod to giving patients more of it.
CUSIP: 88023B103HealthcareUS5 holders
Total Value
$885.66M
Total Shares
17.26M
Net Share Change
+3.02M
Activity
4 buying1 selling
Investor
Value
Shares
Weight
Change
